Powder for preparation of solution for injections Tseftriakson is shown for treatment of infections which causative agents are sensitive to a tseftriakson:
- respiratory infection, especially pneumonia and also infections of an ear, throat and nose;
- an infection of abdominal organs (peritonitis, infections of biliary tract and digestive tract);
- an infection of kidneys and urinary tract;
- an infection of genitals, including gonorrhea;
- sepsis;
- an infection of bones, joints, soft tissues, skin and also wound fevers;
- an infection at patients with the weakened immunity;
- meningitis;
- disseminate borreliosis of Lyme (stages of II and III).
Structure
Active ingredient: ceftriaxone.
1 bottle supports a tseftriakson of sodium is equivalent a tseftriaksona of 1000 mg.
Contraindication
Hypersensitivity to a tseftriakson or to any other cephalosporin. Existence in the anamnesis of heavy reactions of hypersensitivity (for example, anaphylactic) to any other type beta laktamnykh antibacterial agents (penicillin, monobaktamam and to karbapenema).
Route of administration
Drug dose depends on weight, sensitivity, localization and like an infection and also on age and function of a liver and the patient's kidneys.
Feature
Pregnant
during pregnancy, in particular in the first trimester, tseftriakson it is possible to apply, only if the advantage exceeds risk.
Children
apply Medicine to children according to a dosage.
DriversCorresponding researches were not conducted by
. Tseftriakson can affect ability to steer vehicles or to work with difficult mechanisms as emergence of such side reactions as dizziness is possible. Overdose
can be observed by
At overdose nausea, vomiting, diarrhea. In case of overdose the hemodialysis or peritoneal dialysis will not reduce excessive concentration of medicine in blood plasma. Specific antidote does not exist. Overdose treatment symptomatic.
Side effects
Side reactions which were most often observed at application of a tseftriakson is the eosinophilia, a leukopenia, thrombocytopenia, diarrhea, rash and increase in level of liver enzymes.
Interaction
Tseftriakson, as well as other antibiotics, can be the cause of false positive results of the analysis on a galactosemia.
In this way, when determining glucose in urine with the help not fermental results of methods can be false positive. For this reason during application of a tseftriakson it is necessary to determine glucose level in urine by fermental methods.
byRenal failures it was not observed after joint use of high doses of a tseftriakson and powerful diuretics (for example, furosemide).
Storage conditionsto Store
out of children's reach in original packing at a temperature not above 25 °C.
Characteristics | |
Active ingredients | Tseftriakson |
Amount of active ingredient | 1000 mg |
Applicant | Dzhenofarm |
Code of automatic telephone exchange | J01DD04 Tseftriakson |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Generic-generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | bottle |
Producer | NSPS HEBEY HUAMIN PHARMACEUTICAL COMPANY LIMITED |
Quantity in packing | 10 pieces |
Release form | powder for injections |
Route of administration | Intramuscular |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Tseftriakson |
Tseftriakson time. for solution for infection. fl. 1000 mg No. 10
- Product Code: 179393
- In Stock
- Ready to ship
-
$28.45